Post Graduate Course (PG1)

Extending the Boundaries of Antiviral treatment
for Hepatitis B and C

Saturday July 1st 2006, 8.30 to 12.30

Organizers: G. Dusheiko (UK), F. Zoulim (France)

Hepatitis B therapy:

8:30
The limits of current antiviral therapy of chronic hepatitis B (G. Dusheiko, UK)

8:50
Targets for nucleoside analogs and cross resistance testing (F. Zoulim, France)

9:10
Results of clinical trials with new nucleosides analogues (A. Lok, USA)

9:30
Perspectives on combination therapy (J. Petersen, Germany)

9:50
Round table discussion

10:15 Break

Hepatitis C therapy:

10:35
How to improve efficacy and overcome non response with existing therapy (T. Baumert, France)

10:55
Improvements in the offing with new interferons and ribavirins (A.Craxi, Italy)

11:15
Specific inhibitors of HCV replication and drug resistance (J. Neyts, Belgium)
11:35
Results of clinical trials with new protease and polymerase inhibitors (M. Manns, Germany)

11:55
Round table discussion

12:20
Conclusion